Severity of AIDS and the response to EPO in uremia

American Journal of Kidney Diseases

Volumn 30, Issue 1, 1997, Pages 28-35

  Ifudu, Onyekachi ^a   Matthew, Jocelyn J ^b   Mayers, Joan D ^b   Macey, Leila J ^b   Brezsnyak, William ^b   Reydel, Catherine ^b   McClendon, Eunice ^b   Surgrue, Theresa ^b   Rao, T K Sreepada ^b   Friedman, Eli A ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b NONE

Author keywords

Acquired immunodeficiency syndrome; Albumin; Anemia; CD4; End stage renal disease; Erythropoietin; Hematocrit; Hemodialysis; Human immunodeficiency virus; Percent reduction of urea

Indexed keywords

CD4 ANTIGEN; ERYTHROPOIETIN; RECOMBINANT ERYTHROPOIETIN; SERUM ALBUMIN; TRANSFERRIN; UREA;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FEVER; HEMATOCRIT; HEMODIALYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KIDNEY FAILURE; MALE; UREMIA;

EID: 12644252017     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90561-8     Document Type: Article

References (30)

1. Eschbach JW: The anemia of chronic renal failure: Pathophysiology and the effects of recombinant erythropoietin. Kidney Int 35:134-148, 1989
2. Lundin AP: Quality of life: Subjective and objective improvements with recombinant human erythropoietin therapy. Semin Nephrol 9:22-29, 1989
3. Macdougall IC, Allen D, Tucker B, Baker LRI, Raine AEG: Serum interleukin-6 levels are a useful indicator of marrow suppression in patients with resistance to erythropoietin due to inflammatory disease. J Am Soc Nephrol 4:428, 1993 (abstr)
4. Muirhead N, Hodsman AB: Occult infection and resistance of anemia to rHuEPO therapy in renal failure. Nephrol Dial Transplant 5:232-234, 1990
5. Shrivastava D, Rao TKS, Sinert R, Khurana E, Lundin AP, Friedman EA: The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis. Am J Kidney Dis 25:904-909, 1995
6. Hollander M, Wolfe D (eds): Nonparametric Statistical Methods. New York, NY, Wiley, 1973
7. Norusis MJ: Statistical Package for the Social Sciences for Windows Advanced Statistics, Release 6.0. Chicago, IL, SPSS Inc, 1993, pp 1-30
8. Ifudu O, Mayers JD, Matthew JJ, et al: Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: Has the outcome changed in the 1990s. Am J Kidney Dis 29:549-552, 1997
9. Fischl M, Galpin JE, Levine JD, Groopman JE, Henry DH, Kennedy P, Miles S, Robbins W, Starrett B, Zalusky R, Abels RI, Tsai HC, Rudnick SA: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med 322:1488-1493, 1990
10. Ifudu O, Feldman J, Friedman EA: The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease. N Engl J Med 334:420-425, 1996
11. Stegeman CA, Kloppenburg WD, Huisman RM, de Jong PE: The erythropoietin dose correlates with dialysis adequacy in patients on chronic hemodialysis. J Am Soc Nephrol 6:563, 1995 (abstr)
12. Mitsuyasu RT: Hematopoietic growth hormones in HIV, in Volberding P, Jacobson MA (eds): AIDS Clinical Review 1993/1994. New York, NY, Marcel Dekker, 1994, pp 191-213
13. Donahue RE, Johnson MM, Zon LI, Clark SC, Groopman JE: Suppression of in vitro hematopoiesis following human immunodeficiency virus infection. Nature 326:200-203, 1987
14. Hakim RA, Breyer J, Ismail N, Schulman G: Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis 23:661-669, 1994
15. Hamilton LC: Basics of multiple regression, in Hamilton LC (eds): Regression With Graphics. A Second Course in Applied Statistics. Balmont, CA, Duxbury Press, Wadsworth, 1992, pp 66-101
16. Bia MJ, Cooper K, Schnall S, Duffy T, Hendler E, Malluche H, Solomon L: Aluminum induced anemia: Pathogenesis and treatment in patients on chronic hemodialysis. Kidney Int 36:852-858, 1989
17. Rao SD, Shih M, Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328:171-175, 1993
18. Rao TKS, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA: Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 310:669-673, 1984
19. Rao TKS, Friedman EA, Nicastri AD: The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316:1062-1068, 1987
20. Winston JA, Klotman PE: Are we missing an epidemic of HIV-associated nephropathy? J Am Soc Nephrol 7:1-7, 1996
21. Carbone L, D'Agati V, Cheng JT, Appel GB: The course and prognosis of human immunodeficiency virus-associated nephropathy. Am J Med 87:389-395, 1989
22. Rao TK, Manis T, Friedman EA: Dismal prognosis despite maintenance hemodialysis in AIDS nephropathy and chronic uremia. ASAIO Trans 31:160-163, 1985
23. Stein TP, Nutinsky C, Condoluci D, Schluter MD, Leskiw MJ: Protein and energy substrate metabolism in AIDS patients. Metabolism 39:876-881, 1990
24. Koch KM, Patyna WD, Shaldon S, Werner E: Anemia of the regular hemodialysis patient and its treatment. Nephron 12:405-419, 1974
25. Santiago GC, Rao TKS, Laird NM: Effect of dialysis therapy on the hematopoietic system: The National Cooperative Dialysis Study. Kidney Int 23:S95-S100, 1983 (suppl 13)
26. Tzamaloukas AH, Murata GH, Sena P: When do plasma levels of azotemic indices indicate inadequacy of peritoneal dialysis? Nephron 67:495-496, 1994
27. Charra B, Calemard E, Ruffet M, Chazot C, Terrat JC, Vanel T, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
28. Yang CS, Chen SW, Chiang CH, Wang M, Peng SJ, Kan YT: Effects of increasing dialysis dose on serum albumin and mortality in hemodialysis patients. Am J Kidney Dis 27:380-386, 1996
29. Geerlings W, Morris RW, Brunner FP, Brynger H, Enrich JH, Fassbinder W, Rizzoni G, Selwood NH, Tufveson G, Wing AJ: Factors influencing anaemia in dialysis patients. A special survey by the EDTA-ERA Registry. Nephrol Dial Transplant 8:585-589, 1993
30. Ifudu O, Chan E, Paul H, Mayers JD, Cohen LS, Brezsnyak WF, Herman AI, Avram MM, Friedman EA: Anemia severity and missed dialysis treatments in erythropoietin-treated hemodialysis patients. ASAIO J 42:146-149, 1996